Jonathan W Waks1, Kazi T Haq2, Christine Tompkins3, Albert J Rogers4, Ashkan Ehdaie5, Aron Bender2, Jessica Minnier2, Khidir Dalouk6, Stacey Howell2, Achille Peiris5, Merritt Raitt6, Sanjiv M Narayan4, Sumeet S Chugh5, Larisa G Tereshchenko7. 1. Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 2. Department of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon. 3. Department of Medicine, Cardiovascular Division, University of Colorado, Aurora, Colorado. 4. Department of Medicine, Cardiovascular Division, University, Palo Alto, California. 5. Department of Medicine, Cardiovascular Division, Cedars-Sinai Health System, Los Angeles, California. 6. Department of Medicine, Cardiovascular Division, Portland Health Care System, Portland, Oregon. 7. Department of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon. Electronic address: tereshch@ohsu.edu.
Abstract
BACKGROUND: Global electrical heterogeneity (GEH) is associated with sudden cardiac death in the general population. Its utility in patients with systolic heart failure who are candidates for primary prevention (PP) implantable cardioverter-defibrillators (ICDs) is unclear. OBJECTIVE: The purpose of this study was to investigate whether GEH is associated with sustained ventricular tachycardia/ventricular fibrillation leading to appropriate ICD therapies in patients with heart failure and PP ICDs. METHODS: We conducted a multicenter retrospective cohort study. GEH was measured by spatial ventricular gradient (SVG) direction (azimuth and elevation) and magnitude, QRS-T angle, and sum absolute QRST integral on preimplant 12-lead electrocardiograms. Survival analysis using cause-specific hazard functions compared the strength of associations with 2 competing outcomes: sustained ventricular tachycardia/ventricular fibrillation leading to appropriate ICD therapies and all-cause death without appropriate ICD therapies. RESULTS: We analyzed 2668 patients (mean age 63 ± 12 years; 624 (23%) female; 78% white; 43% nonischemic cardiomyopathy; left ventricular ejection fraction 28% ± 11% from 6 academic medical centers). After adjustment for demographic, clinical, device, and traditional electrocardiographic characteristics, SVG elevation (hazard ratio [HR] per 1SD 1.14; 95% confidence interval [CI] 1.04-1.25; P = .004), SVG azimuth (HR per 1SD 1.12; 95% CI 1.01-1.24; P = .039), SVG magnitude (HR per 1SD 0.75; 95% CI 0.66-0.85; P < .0001), and QRS-T angle (HR per 1SD 1.21; 95% CI 1.08-1.36; P = .001) were associated with appropriate ICD therapies. Sum absolute QRST integral had different associations in infarct-related cardiomyopathy (HR 1.29; 95% CI 1.04-1.60) and nonischemic cardiomyopathy (HR 0.78; 95% CI 0.62-0.96) (Pinteraction = .022). CONCLUSION: In patients with PP ICDs, GEH is independently associated with appropriate ICD therapies. The SVG vector points in distinctly different directions in patients with 2 competing outcomes.
BACKGROUND: Global electrical heterogeneity (GEH) is associated with sudden cardiac death in the general population. Its utility in patients with systolic heart failure who are candidates for primary prevention (PP) implantable cardioverter-defibrillators (ICDs) is unclear. OBJECTIVE: The purpose of this study was to investigate whether GEH is associated with sustained ventricular tachycardia/ventricular fibrillation leading to appropriate ICD therapies in patients with heart failure and PP ICDs. METHODS: We conducted a multicenter retrospective cohort study. GEH was measured by spatial ventricular gradient (SVG) direction (azimuth and elevation) and magnitude, QRS-T angle, and sum absolute QRST integral on preimplant 12-lead electrocardiograms. Survival analysis using cause-specific hazard functions compared the strength of associations with 2 competing outcomes: sustained ventricular tachycardia/ventricular fibrillation leading to appropriate ICD therapies and all-cause death without appropriate ICD therapies. RESULTS: We analyzed 2668 patients (mean age 63 ± 12 years; 624 (23%) female; 78% white; 43% nonischemic cardiomyopathy; left ventricular ejection fraction 28% ± 11% from 6 academic medical centers). After adjustment for demographic, clinical, device, and traditional electrocardiographic characteristics, SVG elevation (hazard ratio [HR] per 1SD 1.14; 95% confidence interval [CI] 1.04-1.25; P = .004), SVG azimuth (HR per 1SD 1.12; 95% CI 1.01-1.24; P = .039), SVG magnitude (HR per 1SD 0.75; 95% CI 0.66-0.85; P < .0001), and QRS-T angle (HR per 1SD 1.21; 95% CI 1.08-1.36; P = .001) were associated with appropriate ICD therapies. Sum absolute QRST integral had different associations in infarct-related cardiomyopathy (HR 1.29; 95% CI 1.04-1.60) and nonischemic cardiomyopathy (HR 0.78; 95% CI 0.62-0.96) (Pinteraction = .022). CONCLUSION: In patients with PP ICDs, GEH is independently associated with appropriate ICD therapies. The SVG vector points in distinctly different directions in patients with 2 competing outcomes.
Authors: Jason A Thomas; Erick A Perez-Alday; Allison Junell; Kelley Newton; Christopher Hamilton; Yin Li-Pershing; David German; Aron Bender; Larisa G Tereshchenko Journal: Ann Noninvasive Electrocardiol Date: 2018-11-07 Impact factor: 1.468
Authors: Jonathan W Waks; Colleen M Sitlani; Elsayed Z Soliman; Muammar Kabir; Elyar Ghafoori; Mary L Biggs; Charles A Henrikson; Nona Sotoodehnia; Tor Biering-Sørensen; Sunil K Agarwal; David S Siscovick; Wendy S Post; Scott D Solomon; Alfred E Buxton; Mark E Josephson; Larisa G Tereshchenko Journal: Circulation Date: 2016-04-14 Impact factor: 29.690
Authors: Neal A Chatterjee; Jani T Tikkanen; Gopi K Panicker; Dhiraj Narula; Daniel C Lee; Tuomas Kentta; Juhani M Junttila; Nancy R Cook; Alan Kadish; Jeffrey J Goldberger; Heikki V Huikuri; Christine M Albert Journal: Eur Heart J Date: 2020-06-01 Impact factor: 29.983
Authors: Larisa G Tereshchenko; Alan Cheng; Barry J Fetics; Joseph E Marine; David D Spragg; Sunil Sinha; Hugh Calkins; Gordon F Tomaselli; Ronald D Berger Journal: J Electrocardiol Date: 2010-09-15 Impact factor: 1.438
Authors: Bruce D Gunderson; Athula I Abeyratne; Walter H Olson; Charles D Swerdlow Journal: Pacing Clin Electrophysiol Date: 2007-02 Impact factor: 1.976
Authors: Kenneth A Ellenbogen; Joseph H Levine; Ronald D Berger; James P Daubert; Stephen L Winters; Eugene Greenstein; Alaa Shalaby; Andi Schaechter; Haris Subacius; Alan Kadish Journal: Circulation Date: 2006-02-06 Impact factor: 29.690
Authors: Andrew Oehler; Trevor Feldman; Charles A Henrikson; Larisa G Tereshchenko Journal: Ann Noninvasive Electrocardiol Date: 2014-09-09 Impact factor: 1.468
Authors: Larisa G Tereshchenko; Alan Cheng; Barry J Fetics; Barbara Butcher; Joseph E Marine; David D Spragg; Sunil Sinha; Darshan Dalal; Hugh Calkins; Gordon F Tomaselli; Ronald D Berger Journal: J Electrocardiol Date: 2010-11-20 Impact factor: 1.438
Authors: Kazi T Haq; Katherine J Lutz; Kyle K Peters; Natalie E Craig; Evan Mitchell; Anish K Desai; Nathan W L Stencel; Elsayed Z Soliman; João A C Lima; Larisa G Tereshchenko Journal: J Electrocardiol Date: 2021-10-02 Impact factor: 1.438